FMD Locks South Africa Out of Chinese Beef Market as Vaccine Supplier Scandal Deepens Biosecurity Crisis

By
Stonehaven Analytics
/
Sep 21, 2026

Chinese customs data show South African beef exports have effectively disappeared in 2026, with foot-and-mouth disease restrictions overriding Beijing’s expanded zero-tariff treatment for African partners — while at home, the suspension of Onderstepoort Biological Products’ acting chief executive over FMD vaccine pricing has exposed how far the state-owned manufacturer has drifted from its biosecurity mandate.

China extended zero-tariff treatment to 53 African diplomatic partners this year, but the concession addresses duties rather than quarantine barriers. South Africa’s market access, reopened in 2023 when China recognised certain regions as FMD-free, was suspended from 15 May 2025 following outbreaks reported to WOAH in Mpumalanga and Gauteng — both inside the recognised disease-free zone. The ban covers direct and indirect imports of cloven-hoofed animals and related products.

The trade impact is stark. Chinese import data show South African frozen beef shipments falling from $18.5 million in 2024 to $9.8 million in 2025, with no recorded imports under general trade in the first seven months of 2026.

Domestically, Onderstepoort Biological Products is under parliamentary scrutiny. Acting chief executive Dr Jacob Modumo has been placed on precautionary suspension pending investigation of FMD vaccine pricing. Agriculture minister Willie Aucamp has stated the suspension implies no guilt but insisted any costs added to imported vaccines must be legitimate and transparent.

The figures are uncomfortable. In the final quarter of OBP’s 2025/26 year, local sales reached approximately $12.6 million, of which around $11.8 million came from imported FMD vaccines supplied by Biogénesis Bagó and Dollvet. Just $0.77 million came from OBP’s own products. The Free State reported paying $4.00 to $5.15 per dose, above private procurement rates.

Parliament has criticised OBP for consecutive poor audits and failure to complete a $28 million Good Manufacturing Practice upgrade. The South African Agri Initiative now argues privatisation may be the only credible remedy.

"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."

Scroll to Top